BOCA RATON, Fla., June 8, 2016 /PRNewswire/ -- Sensus
Healthcare, Inc. (NASDAQ: SRTSU) ("Sensus" or the "Company"), a
medical device company specializing in the treatment of
non-melanoma skin cancers and other skin conditions, such as
keloids, with superficial radiation therapy, today announced that
CEO Joe Sardano will ring the Nasdaq
opening bell on Thursday, June 9,
2016 to celebrate the Company's recent IPO.
"We could not think of a more fitting way to culminate months of
hard work preparing Sensus to go public than to ring the Nasdaq
opening bell alongside our partners and friends," said CEO
Joe Sardano. "We believe that Sensus
is at the forefront of a seismic shift in the way healthcare
providers treat non-melanoma skin cancers and keloids. Our IPO not
only provides us with the capital to expand operations but also
gives us increased visibility among members of the financial
community and general public at large, who view Nasdaq as the place
to be for dynamic, high growth public companies."
Sardano will ring the opening bell at 9:30 a.m. ET and will be joined by Sensus
management, board members and medical advisors. The event will be
broadcast live from the Nasdaq MarketSite in New York, starting at 9:15 a.m. ET and viewable online at
https://new.livestream.com/nasdaq/live
About Sensus
Sensus Healthcare, Inc. is a medical device company that is
committed to enabling non-invasive and cost-effective treatment of
non-melanoma skin cancers and keloids. Sensus uses a proprietary
low energy x-ray radiation technology known as superficial
radiation therapy (SRT), which is a result of over a decade of
dedicated research and development activities. Sensus has
successfully incorporated the SRT therapy into its portfolio of
treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the
SRT technology has been used to effectively and safely treat
oncological and non-oncological skin conditions in thousands of
patients. For more information,
visit http://www.sensushealthcare.com.
Investor Relations Contacts:
Jeffrey Goldberger / Allison
Soss
KCSA Strategic Communications
Phone: 212-896-1249 / 212-896-1267
Email: jgoldberger@kcsa.com / asoss@kcsa.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sensus-healthcare-inc-to-ring-the-nasdaq-opening-bell-300281229.html
SOURCE Sensus Healthcare